Virios Therapeutics | 424B4: Prospectus
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | 424B4: Prospectus
Virios Therapeutics | 10-Q: Quarterly report
Virios Therapeutics | 8-K: Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | ARS: Annual Report to Security Holders
Virios Therapeutics | DEF 14A: Definitive information statements
Virios Therapeutics | 10-K/A: Annual report (Amendment)
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | 10-K: Annual report
Virios Therapeutics | 8-K: Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pridgen William
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thomas John C
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Whitley Richard James
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Keefer David R
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burch Richard Alan
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director De La Rosa Abel
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walsh Angela
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grosswald Ralph
No Data